• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项比较盐酸利达脒和洛哌丁胺对症治疗急性腹泻的多中心双盲对照试验。

A multicenter double-blind controlled trial comparing lidamidine HCl and loperamide in the symptomatic treatment of acute diarrhoea.

作者信息

Gasbarrini G, Corazza G R, Feliciani M, Albano O, Stufano N, Altomare E, Fontana G, Valpiani D, Chiodo F, Banterle C

出版信息

Arzneimittelforschung. 1986 Dec;36(12):1843-5.

PMID:3551969
Abstract

The efficacy of 1-(2,6-dimethylphenyl)-3-methyl-amidinourea hydrochloride (lidamidine HCl, WHR-1142 A) an aryl-substituted amidinourea recently synthesized, was compared with that of loperamide in 32 patients with acute diarrhoea. The results of the study show that lidamidine HCl and loperamide had comparable effects in the pharmacological treatment of acute non-specific diarrhoea. Lidamidine HCl was also shown to be well tolerated; side-effects were generally minor and self-limiting.

摘要

1-(2,6-二甲基苯基)-3-甲基脒基脲盐酸盐(利达脒盐酸盐,WHR-1142 A)是一种最近合成的芳基取代脒基脲,对32例急性腹泻患者比较了其与洛哌丁胺的疗效。研究结果表明,利达脒盐酸盐和洛哌丁胺在急性非特异性腹泻的药物治疗中具有相当的效果。利达脒盐酸盐耐受性也良好;副作用一般较小且为自限性。

相似文献

1
A multicenter double-blind controlled trial comparing lidamidine HCl and loperamide in the symptomatic treatment of acute diarrhoea.一项比较盐酸利达脒和洛哌丁胺对症治疗急性腹泻的多中心双盲对照试验。
Arzneimittelforschung. 1986 Dec;36(12):1843-5.
2
[Double-blind evaluation of the effectiveness of lidamidine hydrochloride (WHR-1142A) vs loperamide vs. placebo in the treatment of acute diarrhea].[盐酸利达脒(WHR-1142A)、洛哌丁胺与安慰剂治疗急性腹泻有效性的双盲评估]
Salud Publica Mex. 1981 Sep-Oct;23(5):483-91.
3
[Evaluation of the safety and effectiveness of WHR-1142A in the treatment of non-specific acute diarrhea].WHR-1142A治疗非特异性急性腹泻的安全性和有效性评估
Rev Gastroenterol Mex. 1979 Oct-Dec;44(4):167-73.
4
A double-blind crossover comparison of lidamidine, loperamide and placebo for the control of chronic diarrhoea.利达脒、洛哌丁胺与安慰剂治疗慢性腹泻的双盲交叉对照比较。
Aliment Pharmacol Ther. 1988 Aug;2(4):347-51. doi: 10.1111/j.1365-2036.1988.tb00707.x.
5
Double-blind cross-over study comparing loperamide, codeine and diphenoxylate in the treatment of chronic diarrhea.比较洛哌丁胺、可待因和地芬诺酯治疗慢性腹泻的双盲交叉研究。
Gastroenterology. 1980 Dec;79(6):1272-5.
6
Multicenter, double-blind, randomized comparison of wood creosote, the principal active ingredient of Seirogan, an herbal antidiarrheal medication, and loperamide in adults with acute nonspecific diarrhea.对成人急性非特异性腹泻患者,进行木馏油(一种草药止泻药西罗甘的主要活性成分)与洛哌丁胺的多中心、双盲、随机对照研究。
Clin Ther. 2004 Oct;26(10):1644-51. doi: 10.1016/j.clinthera.2004.10.001.
7
First-line treatment in acute non-dysenteric diarrhoea: clinical comparison of loperamide oxide, loperamide and placebo. UK Janssen Research Group of General Practitioners.急性非痢疾性腹泻的一线治疗:氧化洛哌丁胺、洛哌丁胺与安慰剂的临床比较。英国扬森全科医生研究小组。
Br J Clin Pract. 1995 Jul-Aug;49(4):181-5.
8
Loperamide in the symptomatic control of chronic diarrhoea. Double-blind placebo-controlled study.洛哌丁胺用于慢性腹泻的症状控制。双盲安慰剂对照研究。
Ann Clin Res. 1975 Oct;7(5):325-30.
9
Loperamide (imodium)--clinical trial.洛哌丁胺(易蒙停)——临床试验。
Ther Hung. 1990;38(2):60-3.
10
Loperamide: a new antidiarrheal agent in the treatment of chronic diarrhea.洛哌丁胺:一种治疗慢性腹泻的新型止泻药。
Gastroenterology. 1976 Jun;70(6):1026-9.

引用本文的文献

1
What about clonidine for diarrhoea? A systematic review and meta-analysis of its effect in humans.可乐定治疗腹泻如何?对其在人体中的作用进行的系统评价和荟萃分析。
Therap Adv Gastroenterol. 2016 May;9(3):282-301. doi: 10.1177/1756283X15625586. Epub 2016 Jan 25.
2
Pharmacotherapy: non-serotonergic mechanisms.药物治疗:非5-羟色胺能机制
Gut. 2002 Jul;51 Suppl 1(Suppl 1):i87-90. doi: 10.1136/gut.51.suppl_1.i87.